Neurana has received investments from a number of high net worth individuals as well as MagnaSci Ventures. MagnaSci Ventures is a Houston based healthcare fund focused on investing in early stage life science companies with exceptional science and entrepreneurs. MagnaSci has a $20 million fund, with an additional $50 million in co-investment potential from its Limited Partners.

Could Tolperisone be to the muscle spasm market what "non-drowsy" is to the allergy market?